Role of tumor necrosis factor-alpha–308 G/A and interleukin-10 promotor–592 C/A polymorphisms in adult immune thrombocytopenic purpura
Abstract
Introduction: Immune thrombocytopenia (ITP) pathogenesis has been related to cytokine imbalance, which is controlled genetically with gene polymorphisms. The correlation of the interleukin (IL)-10 gene and tumor necrosis factor alpha (TNF-α) polymorphisms with ITP susceptibility has been previously investigated, but the association with clinical and prognostic parameters remains unclear. Material and methods: To investigate the relation between IL-10-592 C/A and TNF-α-308 G/A gene polymorphisms and their clinical significance in adult patients with ITP. This study was conducted on 40 ITP patients and 40 control individuals. The IL-10-592 C/A polymorphism was genotyped by the polymerase chain reaction-restriction fragment length polymorphism method and the TNF- α-308 G/A polymorphism by amplification refractory mutation system analysis. Results: The TNF-α-308 G/A polymorphism was significantly associated with low platelet count, wet purpura, higher bleeding score, higher incidence of complications, and lack of response to steroid therapy. The IL-10-592 C/A polymorphism was not significantly associated with any of these parameters. Conclusion: We found a significant association between the TNF-α-308 G/A polymorphism and several clinical parameters, which suggests a probable role in the prognosis among adult ITP patients.
Keywords: immune thrombocytopenic purpurapolymorphisminterleukin 10 promotor genetumor necrosis factor-alpha geneprognosis
References
- El Ghannam D, Fawzy IM, Azmy E, et al. Relation of interleukin-10 promoter polymorphisms to adult chronic immune thrombocytopenic purpura in a cohort of Egyptian population. Immunol Invest. 2015; 44(7): 616–626.
- Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009; 113(11): 2386–2393.
- Schulze H, Gaedicke G. Immune thrombocytopenia in children and adults: what's the same, what's different? Haematologica. 2011; 96(12): 1739–1741.
- Blanchette V, Bolton-Maggs P. Childhood immune thrombocytopenic purpura: diagnosis and management. Hematol Oncol Clin North Am. 2010; 24(1): 249–273.
- Negi RR, Bhoria P, Pahuja A, et al. Investigation of the possible association between the HLA antigens and idiopathic thrombocytopenic purpura (ITP). Immunol Invest. 2012; 41(2): 117–128.
- Moolman-Smook J, De Lange W, Corfield V, et al. Expression of HCM causing mutations: lessons learnt from genotype-phenotype studies of the South African founder MYH7 A797T mutation. J Med Genet. 2000; 37(12): 951–956.
- Qidwai T, Khan F. Tumour necrosis factor gene polymorphism and disease prevalence. Scand J Immunol. 2011; 74(6): 522–547.
- Hajeer AH, Hutchinson I. Influence of TNFα gene polymorphisms on TNFα production and disease. Hum Immunol. 2001; 62(11): 1191–1199.
- Tekeli O, Turacli ME, Egin Y, et al. Tumor necrosis factor alpha-308 gene polymorphism and pseudoexfoliation glaucoma. Mol Vis. 2008; 14: 1815–1818.
- Akar N, Hasipek M. Tumour necrosis factor-alpha gene polymorphism (-308 G-A) in Turkish pediatric thrombosis patients. Turk J Haematol. 2002; 19(1): 39–41.
- Najafi S, Moqadam IF, Mohammadzadeh M, et al. Interleukin-10 genepolymorphisms in recurrent aphthous stomatitis. Immunol Invest. 2014; 43(4): 405–409.
- Movahedi M, Mahdaviani S, Rezaei N, et al. IL-10, TGF-ß, IL-2, IL-12, and IFN-γ cytokine gene polymorphisms in asthma. J Asthma. 2009; 45(9): 790–794.
- Liu J, Song B, Bai X, et al. Association of genetic polymorphisms in the interleukin-10 promoter with risk of prostate cancer in Chinese. BMC Cancer. 2010; 10: 456.
- Ou Y, Yang Y, Xiang X, et al. Relationship between the IL-10 (−1082 A/G) polymorphism and the risk of immune/idiopathic thrombocytopenic purpura: A meta-analysis. Cytokine. 2020; 125: 154820.
- George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996; 88(1): 3–40.
- Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010; 115(2): 168–186.
- George JN AD, Leung LL, Tirnauer JS. Immune thrombocytopenia (ITP) in adults: Initial treatment and prognosis. UpToDate Walthma, Massachusetts 2018. https://www.uptodate.com/contents/immune-thrombocytopenia-itp-in-adults-clinical-manifestations-and-diagnosis (January 1, 2021).
- Wei Yu, Ji Xb, Wang Yw, et al. High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial. Blood. 2016; 127(3): 296–302; quiz 370.
- Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009; 113(11): 2386–2393.
- Bergmann AK, Grace RF, Neufeld EJ. Genetic studies in pediatric ITP: outlook, feasibility, and requirements. Ann Hematol. 2010; 89 Suppl 1: S95–103.
- Lin MT, Storer B, Martin PJ, et al. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med. 2003; 349(23): 2201–2210.
- Núñez C, Alecsandru D, Varadé J, et al. Interleukin-10 haplotypes in celiac disease in the Spanish population. BMC Med Genet. 2006; 7: 32.
- Eskdale J, Kube D, Tesch H, et al. Mapping of the human IL10 gene and further characterization of the 5' flanking sequence. Immunogenetics. 1997; 46(2): 120–128.
- Popa C, Netea MG, van Riel PL, et al. The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J Lipid Res. 2007; 48(4): 751–762.
- Beutler BD, Cohen PR, Beutler B, et al. The complex regulation and biology of TNF (cachectin). Crit Rev Oncog. 1990; 2(1): 9–18.
- El Sissy MH, El Sissy AH, Elanwary S. Tumor necrosis factor-α -308G/A gene polymorphism in Egyptian children with immune thrombocytopenic purpura. Blood Coagul Fibrinolysis. 2014; 25(5): 458–463.
- Satoh T, Pandey JP, Okazaki Y, et al. Single nucleotide polymorphisms of the inflammatory cytokine genes in adults with chronic immune thrombocytopenic purpura. Br J Haematol. 2004; 124(6): 796–801.
- Saitoh T, Kasamatsu T, Inoue M, et al. Interleukin-10 gene polymorphism reflects the severity of chronic immune thrombocytopenia in Japanese patients. Int J Lab Hematol. 2011; 33(5): 526–532.
- Wu KH, Peng CT, Li TC, et al. Interleukin 4, interleukin 6 and interleukin 10 polymorphisms in children with acute and chronic immune thrombocytopenic purpura. Br J Haematol. 2005; 128(6): 849–852.
- Okulu E, İleri T, Koşan Çulha V, et al. The role of tumor necrosis factor-alpha -308 G/A and transforming growth factor-beta 1 -915 G/C polymorphisms in childhood idiopathic thrombocytopenic purpura. Turk J Haematol. 2011; 28(3): 170–175.